Skip to content
MedsAcross

Medicine

Asmanex 220 mcg inhalant

Mometasone furoate · Inhalation · Organon
Available on requestPrescription onlyUS FDA

Asmanex 220 mcg inhalant is a prescription medicine containing Mometasone furoate for inhalation use, marketed by Organon, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store in a dry place at 25°C (77°F), excursions permitted to 15°C to 30°C…

Key facts

Active ingredient (INN)
Mometasone furoate
Brand
Asmanex
Strength
220 mcg
Dosage form
Inhalant
Route
Inhalation
Packs
1 pouch and 1 more
Marketing authorisation holder
Organon
Manufacturer
Organon
Origin register
US FDA, United States
Storage
Store in a dry place at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
R01AD09 Mometasone furoate
HS code (indicative)
3004.32Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 June 2021
Identifiers
RxCUI 746803, 746804, 746810 +7DailyMed set ID 10b36fb2-6b0d-4f20-b197-3564d6f594b9NDC 78206-114Application NDA021067

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 pouch in 1 carton / 1 inhaler in 1 pouch / 120 inhalant in 1 inhaler78206-114-01Organon1 June 2021
1 pouch in 1 carton / 1 inhaler in 1 pouch / 60 inhalant in 1 inhaler78206-114-02Organon1 June 2021
1 pouch in 1 carton / 1 inhaler in 1 pouch / 14 inhalant in 1 inhaler78206-114-03Organon1 June 2021
1 pouch in 1 carton / 1 inhaler in 1 pouch / 30 inhalant in 1 inhaler78206-114-04Organon1 June 2021

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 30 April 1987Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Mometasone furoate

Clinical summary

Mometasone furoate is a corticosteroid indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 4 years of age and older, among other approved uses. MedsAcross supplies Mometasone furoate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Mometasone furoate

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Asmanex 220 mcg inhalant for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.